Venture Visionary Partners’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-641
Closed -$35.7K 1070
2022
Q2
$35.7K Buy
+641
New +$35.7K ﹤0.01% 881